Archived story1 article · 1 publisher
Big Pharma’s China deal spree grows with latest tie-up worth up to $7.8 billion
- Published
- Updated
- Reports
- 1 from 1 publisher
Western biopharma companies are increasingly turning to China to source innovation, as pharma's dreaded "patent cliff" draws closer.
Morning briefing · free
The 10 stories everyone is covering, in your inbox at 7 am your time.
grouped.news is free, independent and has no paywall. If it saves you time, chip in.Buy us a coffee ↗